RUSSELL, Alan James,MUCI, Alex,LU, Pu-Ping,MORGANS Jr., David J.,FINER, Jeffrey T.,MORGAN, Bradley P.
申请号:
AU2016202040
公开号:
AU2016202040A1
申请日:
2016.04.01
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
#$%^&*AU2016202040A120160421.pdf#####Abstract Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of obesity, sarcopenia, wasting syndrome, frailty, cachexia, muscle spasm, post-surgical and post-traumatic muscle weakness, neuromuscular disease, and other indications.